Max Healthcare Institute Zukünftiges Wachstum
Future Kriterienprüfungen 5/6
Max Healthcare Institute wird ein jährliches Gewinn- und Umsatzwachstum von 30.8% bzw. 27.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 30.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 16.9% betragen.
Wichtige Informationen
30.8%
Wachstumsrate der Gewinne
30.5%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 27.4% |
| Wachstumsrate der Einnahmen | 27.3% |
| Zukünftige Eigenkapitalrendite | 16.9% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 18 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Nov 09
Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know
May 25Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Recent updates
Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Nov 09Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now
Sep 14Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Jul 18Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark
Jun 21Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know
May 25Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today
Apr 14Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors
Mar 18Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly
Jan 08Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable
Dec 18With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Sep 20Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?
Jul 07Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Jun 19Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now
Apr 11With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Mar 15Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Feb 22Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet
Nov 22Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly
Jul 15Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly
Mar 09Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals
Nov 24Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 3/31/2027 | 126,118 | 24,191 | 14,896 | 27,878 | 19 |
| 3/31/2026 | 105,655 | 19,522 | 8,648 | 22,434 | 20 |
| 3/31/2025 | 82,519 | 14,641 | -1,550 | 18,253 | 20 |
| 9/30/2024 | 60,083 | 10,590 | 2,649 | 13,125 | N/A |
| 6/30/2024 | 56,640 | 10,538 | N/A | N/A | N/A |
| 3/31/2024 | 54,060 | 10,576 | 3,359 | 11,218 | N/A |
| 12/31/2023 | 51,976 | 10,570 | N/A | N/A | N/A |
| 9/30/2023 | 50,044 | 9,901 | 7,141 | 11,564 | N/A |
| 6/30/2023 | 47,807 | 11,708 | N/A | N/A | N/A |
| 3/31/2023 | 45,626 | 11,035 | 9,485 | 12,841 | N/A |
| 12/31/2022 | 42,799 | 9,763 | N/A | N/A | N/A |
| 9/30/2022 | 41,143 | 9,437 | 3,873 | 9,507 | N/A |
| 6/30/2022 | 39,976 | 6,310 | N/A | N/A | N/A |
| 3/31/2022 | 39,366 | 6,051 | 1,872 | 7,405 | N/A |
| 12/31/2021 | 37,978 | 5,510 | N/A | N/A | N/A |
| 9/30/2021 | 36,193 | 4,516 | 1,486 | 3,086 | N/A |
| 6/30/2021 | 32,486 | 3,236 | N/A | N/A | N/A |
| 3/31/2021 | 25,080 | -1,375 | -6 | 1,179 | N/A |
| 12/31/2020 | 27,772 | -1,177 | N/A | N/A | N/A |
| 9/30/2020 | 22,487 | -2,134 | 3,024 | 3,911 | N/A |
| 6/30/2020 | 14,849 | -2,681 | N/A | N/A | N/A |
| 3/31/2020 | 10,590 | 590 | -130 | 771 | N/A |
| 12/31/2019 | 10,081 | 268 | N/A | N/A | N/A |
| 9/30/2019 | 18,609 | 720 | N/A | N/A | N/A |
| 6/30/2019 | 17,719 | 360 | N/A | N/A | N/A |
| 3/31/2019 | 16,939 | -30 | -268 | 890 | N/A |
| 6/30/2018 | 17,053 | -704 | N/A | N/A | N/A |
| 3/31/2018 | 17,303 | -302 | N/A | 822 | N/A |
| 3/31/2017 | 16,085 | -14 | N/A | 1,561 | N/A |
| 3/31/2016 | 14,343 | -180 | N/A | 7,225 | N/A |
| 3/31/2015 | 7,896 | -381 | N/A | 387 | N/A |
| 3/31/2014 | 9,445 | -646 | N/A | 732 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: MAXHEALTHDas prognostizierte Gewinnwachstum (30.8% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: MAXHEALTHDie Erträge des Unternehmens (30.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (17.9% pro Jahr).
Hohe Wachstumserträge: MAXHEALTHEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: MAXHEALTHDie Einnahmen des Unternehmens (27.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.4% pro Jahr).
Hohe Wachstumseinnahmen: MAXHEALTHDie Einnahmen des Unternehmens (27.3% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: MAXHEALTHDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.9%).